PM360

APRIL 22, 2024

Understanding the “why” before the “how” as Med Affairs charts the course for pre- and post-launch strategies. With a focus on patient-centricity, data-driven insights, and collaborative partnerships across the healthcare ecosystem, it’s redefining the playbook for market shaping and building advocacy for a product pre- and post-launch.

Medical 52

Medical Healthcare Healthcare Education 52

Pharmaceutical Technology

DECEMBER 15, 2022

In an expanded version of the sales forecast from GlobalData’s June 2022 publication, Cardiomyopathies: Global Drug Forecast and Market Analysis , the global cardiomyopathies market is expected to grow from $3.07bn last year to $9.63bn in 2031. The second highest contributing market is APAC, generating 33.2%

Marketing 52

Marketing Sales Healthcare Healthcare 52

pharmaphorum

DECEMBER 12, 2022

Updated results from the ADVANCE IV study of Vyvgart (efgartigimod alfa) showed that more than half of patients with ITP treated with Argenx’ drug showed an improvement in platelet counts, which are dramatically reduced in the disorder. After 24 weeks, 21.8%

Side effects 52

Side effects Sales Competition Patients 52

pharmaphorum

NOVEMBER 24, 2022

Both drugs were given on top of standard antidepressants to patients wo had failed a least two earlier treatments. One issue has been the cost of the drug, with health technology assessment agency NICE in the UK and the ICER organisation in the US both concluding its price tag means it is not a cost-effective option for health systems.

Sales 52

Sales Patients Competition Marketing 52

pharmaphorum

DECEMBER 23, 2022

There’s been huge progress in treatments for blood cancer in recent years – but drawbacks of expensive CAR-T cell and injected antibody therapies have led drug developers to look at novel oral therapies as patient-friendly alternatives. Results suggest durable epigenetic re-wiring and provide rationale for intermittent clinical dosing.

Side effects 52

Side effects Patients Medical Medicine 52

PM360

OCTOBER 13, 2023

Another capability made possible by fine-tuning is the enhancement of content tagging. Content tagging has always been a labor-intensive task. Auto-tagging ensures that the right content efficiently reaches the right customers. Fine-tuning models can target domains and generate prompts to tag the content into relevant topics.

Marketing 64

Marketing Specialization Healthcare Healthcare 64

World of DTC Marketing

DECEMBER 13, 2021

As cancer survival rates rise, so do the price tags of life-saving treatments. Monthly drugs costs may reach $100,000, causing many Americans to struggle with the physical and emotional effects of high out-of-pocket medical costs. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug.

Food and Drug Administration 55

Food and Drug Administration Food Medical Medicine 55

Contrarian Sales Techniques

JANUARY 23, 2024

It delves into the science behind the drugs, equipping you with knowledge of anatomy, physiology, and therapeutic areas. Some found the material dense, the exam daunting, and the price tag a tad hefty. Imagine a treasure map, guiding you through the pharmaceutical jungle. But not every soldier's tale is a fairy tale.

Pharmaceutical Sales 52

Pharmaceutical Sales Pharmaceutical Sales Ethics 52

PM360

APRIL 7, 2023

The shift toward longer, more adequate timeframes to establish proof of concept can be as long as three to four years, 1 given the complex requirements for developing and launching specialty drugs and cell and gene therapies (CGTs) for individuals with complex conditions or rare or orphan diseases.

Manufacturing 52

Manufacturing Marketing Patients Safety 52

pharmaphorum

AUGUST 26, 2022

million for the one-shot therapy – in other words, after any discounts that it may offer or outcomes-based agreements – aiming to launch first in Germany followed by France. BioMarin has said Roctavian will be available at a ‘net’ price of around €1.5 million spread over five years. million spread over five years.

FDA 109

FDA Marketing Competition Patients 109

Map My Customers

AUGUST 2, 2022

For the sales rep, in general, this role means promoting the features and benefits of the product(s), providing consultations on their use, answering questions, and introducing new products when they launch. Surgical Equipment Sales - This type of rep will be selling specialized surgery equipment that often comes with a high price tag.

Medical sales reps 79

Medical sales reps Medical sales Sales Medical 79

Pharmaceutical Technology

JANUARY 27, 2023

On January 18, Sanofi launched a new warranty program for its rare blood disorder drug Cablivi (caplacizumab), which tackles value-based agreements in a slightly different way. Cablivi stops platelets from clumping together, which prevents small clots, and can be used along with other drugs that suppress the immune system.

Patients 52

Patients Pharmaceutical Manufacturing Healthcare Provider 52

Evolve Your Success

DECEMBER 27, 2022

They also wanted to launch a brand for the OR. They launched a couple of years ago. You could say the rest is history because our first podcast launched in January of 2021, and we are still going strong. You can’t put a price tag on that relationship, especially when you’re like, “I need help. What does First Case do ?

Medical sales 52

Medical sales Medical sales reps Sales Medical 52

Pharmaceutical Technology

MARCH 17, 2023

These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. Thus, a higher risk score reflects a more hostile market access environment and drug launch in a geographical area.

Marketing 102

Marketing Pharma Pharmaceutical Healthcare 102

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

NOVEMBER 30, 2022

In what’s being called a “medical bypass”, new anti-obesity drugs are almost matching efficacy rates in weight loss that have previously only been seen with weight loss surgeries. The drug was approved to treat type 2 diabetes mellitus in May. The drug was approved to treat type 2 diabetes mellitus in May. million in Q3.

Medical 98

Medical Manufacturing Insurance Side effects 98